Artificial Cornea and Corneal Implant Market Analysis and Forecast to 2031: By Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior Lamellar Keratoplasty, Keratoprosthesis), Disease Indication (Fuchs’ Dystrophy, Fungal Keratitis, Keratoconus, Others), End Users (Hospitals & Ambulatory Surgical Centers, Speciality Clinics), and Region

The global artificial cornea and corneal implants market size was USD 420 Mn in 2021 and is anticipated to reach USD 752 Mn in 2031, growing at a rate of 6.0 % from 2022 to 2031.

A cornea transplant (keratoplasty) is a surgical procedure to substitute part of the cornea with corneal tissue from a donor. The cornea is the transparent, dome-shaped surface of the eye. It’s where light enters the eye and is a large part of the eye’s ability to see clearly. A cornea transplant may restore vision, reduce pain, and improve the appearance of a damaged or diseased cornea. Most cornea transplant procedures are successful. But cornea transplant carries a small risk of complications, like the rejection of the donor cornea.

Scope of the Report
Report Attribute Details
Market Size in 2021$420 Mn
Market Size in 2031$752 Mn
Growth Rate (2021-31)6.0%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredType, Transplant Type, Disease Indication, End User, and Regions
Key CompaniesAJL Ophthalmic, CorneaGen Inc, CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH and EyeYon Medical
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Global Cornea and Corneal Implants Market Drivers

Increasing Prevalence of eye diseases

The number of people with major eye diseases is increasing worldwide, and vision loss is becoming a major public health concern. The growth in the aging population coupled with the increasing prevalence of chronic disorders like diabetes and hypertension have raised the prevalence of eye diseases such as diabetic retinopathy and ocular hypertension (glaucoma). The number of blind individuals or those affected with low vision is also expected to increase extensively. According to the Royal National Institute of Blind People (RNIB), in 2013, around 2 million people in the UK were living with vision loss, and this figure is likely to increase to 4.1 million by 2050. Presently, there are 146 million people worldwide with trachoma, of which 10 million suffer from trichiasis and need surgery to prevent corneal blindness and 4.9 million individuals are completely blind from trachomatous corneal scarring. Moreover, as per the “World Report on Vision 2019” by WHO, nearly 2.2 people worldwide have vision impairment or blindness. This figure includes several eye conditions that include moderate to severe distance vision impairment or blindness owing to unaddressed refractive errors (123.7 million) and presbyopia (1.8 billion, including both addressed and unaddressed presbyopia), age-related macular degeneration (10.4 million), cataract (65.2 million), corneal opacities (4.2 million), glaucoma (6.9 million), trachoma (2 million), diabetic retinopathy (3 million), and other causes (37.1 million), and people with mild vision impairment with unknown causes (188.5 million).

Global Cornea and Corneal Implants Market Opportunities

Shortage of corneal donors

There is a significant requirement for corneal donors across the globe, as approximately 10 million people need corneal transplants. Densely populated counties such as India suffer from a significant shortage of donor corneas, and there is a waiting period of more than six months for corneal transplants among patients suffering from corneal blindness. Approximately 6.8 million people in the country have poor vision in one eye, and nearly one million people have poor vision in both eyes due to corneal disorders. It was anticipated that by the end of 2020, India would suffer from 10.6 million cases of unilateral corneal blindness. In 2019, around 120,000 people were affected by corneal blindness. About 250,000 corneas are needed annually in the country; still, the total number of corneas donated each year is around 25,000. The high burden of corneal blindness, combined with a shortage of corneal donors, is likely to offer high-growth opportunities to manufacturers of corneal implants.

Global Cornea and Corneal Implants Market Restraints

High cost of ophthalmology devices and surgical procedures

Technological advancements in ophthalmic lasers, like the development of femtosecond lasers, have reduced surgery times and improved procedural outcomes and convenience. But, the high cost of these instruments is expected to restrain their growth. According to a study conducted by the Singapore Eye Research Institute (SERI), the cost of a femtosecond laser was USD 400,000–USD 550,000. This affects their adoption among end users, as it is difficult to estimate the number of patients choosing femtosecond laser therapy over conventional methods and whether the number of patients choosing the therapy will cover the installation cost of the laser. Likewise, the cost of an OCT ranges from USD 70,000 to USD 120,000, and the cost of new fundus machines range from USD 15,000 to USD 60,000.

Impact of COVID-19 on Cornea and Corneal Implant Market

Due to the COVID-19 outbreak, there has been a significant drop in the number of patient visits to clinics in the first and second quarters of 2020 owing to lockdowns and constraints implemented to prevent the spread of the disease. This has led to a decline in the number of elective eye surgeries being conducted per week in hospitals and clinics during the forecast period. According to the Ophthalmology Times article, elective surgeries have reduced from 200 surgeries to only ten surgeries a week. Additionally, countries like the US have witnessed 15% cancellations in the number of patient visits to examination centers. According to the same article, ophthalmology lost a significant share of patient volume during the coronavirus disease (COVID-19) pandemic. It is estimated that ophthalmic practice volume fell by 81%, led by declination in patients seeking care for glaucoma (88%) and cataract surgery (97%). During this period, government programs helped many practices, like Paycheck Protection Program loans, which helped the ophthalmic industry to restart its operations successfully.

Cornea and Corneal Implant Market Segmental Analysis

The report covers the cornea and corneal implant market by type, transplant type, disease indication, end-user, and region.

Global Cornea and Corneal Implant Market by Type

The various types comprised in the global cornea and corneal implant market are the human cornea and artificial cornea.

The human cornea segment is likely to hold a major market share during the forecast period. The key factors boosting the growth of the market are rising awareness regarding corneal transplantation and eye tissue donations majorly in developing countries.

Global Cornea and Corneal Implant Market by Transplant Type

The various transplant types comprised in the global cornea and corneal implant market are penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and Keratoprosthesis.

The penetrating keratoplasty segment is likely to hold the majority of the market share during the forecast period. The factors boosting market growth are the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.

Global Cornea and Corneal Implant Market by Disease Indication

The various disease indications comprised in the global cornea and corneal implant market are fuchs’ dystrophy, fungal keratitis, keratoconus, and others.

The fuchs’ dystrophy segment is likely to hold a major market share during the forecast period. The key factors such as the increasing incidence of the disease and the growing awareness among people regarding early disease diagnosis are driving the market growth.

Global Cornea and Corneal Implant Market by End User

The various end user such as hospitals & ambulatory surgical centers and specialty clinics are comprised in the artificial cornea and corneal implants market.

The hospitals & ambulatory surgical centers segment is likely to dominate the global cornea and corneal implant market during the forecast period. The key factors such as rising incidences of corneal blindness coupled with increasing cases of trauma cases is propelling the growth of the global cornea and corneal implant market.

Geographical Analysis of Global Cornea and Corneal Implant Market

The global cornea and corneal implant market is studied for key countries of the regions such as North America, Europe, Asia Pacific, and the Rest of the World.

North America is likely to hold the majority of the market share of the global cornea and corneal implant market. The market is well established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure combined with higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmologic devices, and a large number of manufacturers for corneal implants in the regions.

Market Players of Global Cornea and Corneal Implants Market

The key players in the global cornea and corneal implants market are AJL Ophthalmic, CorneaGen Inc, CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH and EyeYon Medical among others.

Key Developments in Global Cornea and Corneal Implants Market
  • June 2020: AJL Ophthalmic received CE Mark approval for ENDO-K PRO. Product approval will enable the company to provide its portfolio to end-users.
  • January 2020: Mediphacos launched Keraring Intrasomal Corneal Ring. The product launch will enable the company to capture market share.

 

Why GIS?

Table of Contents

Chapter 1. MARKET INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION AND RESEARCH & SCOPE
1.3. RESEARCH METHODOLOGIES
1.4. MARKET ESTIMATION TECHNIQUES

Chapter 2. EXECUTIVE SUMMARY
2.1. SUMMARY
2.2. KEY HIGHLIGHTS OF THE MARKET

Chapter 3. ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET OUTLOOK
3.1. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET SEGMENTATION
3.2. MARKET DYNAMICS
3.2.1. MARKET DRIVERS
3.2.1.1. DRIVER 1
3.2.1.2. DRIVER 2
3.2.1.3. DRIVER 3
3.2.2. MARKET RESTRAINTS
3.2.2.1. RESTRAINT 1
3.2.2.2. RESTRAINT 2
3.2.3. MARKET OPPORTUNITIES
3.2.3.1. OPPORTUNITY 1
3.2.3.2. OPPORTUNITY 2
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. THREAT OF NEW ENTRANTS
3.3.2. THREAT OF SUBSTITUTES
3.3.3. BARGAINING POWER OF BUYERS
3.3.4. BARGAINING POWER OF SUPPLIER
3.3.5. COMPETITIVE RIVALRY
3.4. PESTLE ANALYSIS
3.5. VALUE CHAIN ANALYSIS
3.5.1. RAW MATERIAL SUPPLIERS
3.5.2. MANUFACTURERS
3.5.3. WHOLESALERS AND/OR RETAILERS
3.6. IMPACT OF RUSSIA AND UKRAINE WAR ON THE GLOBAL CORNEA AND CORNEAL IMPLANTS MARKET

Chapter 4. ECONOMIC IMPACT OF COVID-19
4.1. OVERALL IMPACT OF COVID-19
4.2. IMPACT OF COVID ON THE GLOBAL CORNEA AND CORNEAL IMPLANTS MARKET
4.3. ECONOMIC IMPACT ANALYSIS

Chapter 5. CORNEA AND CORNEAL IMPLANTS MARKET BY TYPE
5.1. MARKET OVERVIEW
5.2. HUMAN CORNEA
5.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.3. ARTIFICIAL CORNEA
5.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)

Chapter 6. CORNEA AND CORNEAL IMPLANTS MARKET BY TRANSPLANT TYPE INSIGHTS & TRENDS
6.1. MARKET OVERVIEW
6.2. PENETRATING KERTOPLASTY
6.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
6.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
6.3. ENDOTHELIAL KERATOPLASTY
6.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
6.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
6.4. ANTERIOR LAMELLAR KERATOPLASTY
6.4.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
6.4.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
6.5. KERATOPROSTHESIS
6.5.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
6.5.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)

Chapter 7. CORNEA AND CORNEAL IMPLANTS MARKET BY DISEASE INDICATION
7.1. MARKET OVERVIEW
7.2. FUSCHS’ DYSTROPHY
7.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.3. FUNGAL KERATITIS
7.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.4. KERATOCONUS
7.4.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.4.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.5. OTHERS
7.5.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.5.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)

Chapter 8. CORNEA AND CORNEAL IMPLANTS MARKET BY END USER
8.1. MARKET OVERVIEW
8.2. HOSPITALS & AMBULATORY SURGICAL CENTERS
8.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
8.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
8.3. SPECIALITY CLINICS
8.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
8.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)

Chapter 9. CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION
9.1. OVERVIEW
9.2. NORTH AMERICA
9.2.1. KEY MARKET TRENDS AND OPPORTUNITIES
9.2.2. NORTH AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.2.3. NORTH AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.2.4. NORTH AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.2.5. NORTH AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.2.6. NORTH AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
9.2.7. THE U.S.
9.2.7.1. THE U.S. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.2.7.2. THE U.S. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.2.7.3. THE U.S. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.2.7.4. THE U.S. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.2.8. CANADA
9.2.8.1. CANADA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.2.8.2. CANADA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.2.8.3. CANADA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.2.8.4. CANADA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.2.9. MEXICO
9.2.9.1. MEXICO CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.2.9.2. MEXICO CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.2.9.3. MEXICO CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.2.9.4. MEXICO CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3. EUROPE
9.3.1. KEY MARKET TRENDS AND OPPORTUNITIES
9.3.2. EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.3. EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.4. EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.5. EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.6. EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
9.3.7. GERMANY
9.3.7.1. GERMANY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.7.2. GERMANY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.7.3. GERMANY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.7.4. GERMANY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.8. FRANCE
9.3.8.1. FRANCE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.8.2. FRANCE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.8.3. FRANCE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.8.4. FRANCE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.9. U.K.
9.3.9.1. U.K. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.9.2. U.K. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.9.3. U.K. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.9.4. U.K. CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.10. SPAIN
9.3.10.1. SPAIN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.10.2. SPAIN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.10.3. SPAIN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.10.4. SPAIN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.11. ITALY
9.3.11.1. ITALY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.11.2. ITALY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.11.3. ITALY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.11.4. ITALY CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.12. RUSSIA
9.3.12.1. RUSSIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.12.2. RUSSIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.12.3. RUSSIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.12.4. RUSSIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.3.13. REST OF EUROPE
9.3.13.1. REST OF EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.3.13.2. REST OF EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.3.13.3. REST OF EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.3.13.4. REST OF EUROPE CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.4. ASIA-PACIFIC
9.4.1. KEY MARKET TRENDS AND OPPORTUNITIES
9.4.2. ASIA-PACIFIC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
9.4.3. ASIA-PACIFIC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.4.4. ASIA-PACIFIC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.4.5. ASIA-PACIFIC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.4.6. ASIA-PACIFIC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.4.7. CHINA
9.4.7.1. CHINA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.4.7.2. CHINA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.4.7.3. CHINA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.4.7.4. CHINA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.4.8. INDIA
9.4.8.1. INDIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.4.8.2. INDIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.4.8.3. INDIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.4.8.4. INDIA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.4.9. JAPAN
9.4.9.1. JAPAN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.4.9.2. JAPAN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.4.9.3. JAPAN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.4.9.4. JAPAN CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.4.10. SOUTH KOREA
9.4.10.1. SOUTH KOREA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.4.10.2. SOUTH KOREA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.4.10.3. SOUTH KOREA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.4.10.4. SOUTH KOREA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.4.11. REST OF APAC
9.4.11.1. REST OF APAC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.4.11.2. REST OF APAC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.4.11.3. REST OF APAC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.4.11.4. REST OF APAC CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.5. REST OF THE WORLD
9.5.1. KEY MARKET TRENDS AND OPPORTUNITIES
9.5.2. REST OF THE WORLD CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.5.3. REST OF THE WORLD CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.5.4. REST OF THE WORLD CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.5.5. REST OF THE WORLD CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.5.6. REST OF THE WORLD CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
9.5.7. LATIN AMERICA
9.5.7.1. LATIN AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.5.7.2. LATIN AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.5.7.3. LATIN AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.5.7.4. LATIN AMERICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.5.8. MIDDLE EAST
9.5.8.1. MIDDLE EAST CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.5.8.2. MIDDLE EAST CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.5.8.3. MIDDLE EAST CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.5.8.4. MIDDLE EAST CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
9.5.9. AFRICA
9.5.9.1. AFRICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
9.5.9.2. AFRICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
9.5.9.3. AFRICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
9.5.9.4. AFRICA CORNEA AND CORNEAL IMPLANTS MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)

Chapter 10. COMPETITIVE LANDSCAPE
10.1. MARKET OVERVIEW
10.2. MARKET SHARE ANALYSIS/KEY PLAYER POSITIONING
10.3. DEVELOPMENTAL STRATEGY BENCHMARKING
10.3.1. NEW PRODUCT DEVELOPMENT
10.3.2. PRODUCT LAUNCHES
10.3.3. BUSINESS EXPANSIONS
10.3.4. PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS
10.3.5. MERGERS AND ACQUISITIONS

Chapter 11. COMPANY PROFILES
11.1. AJL OPHTHALMIC
11.1.1. COMPANY SNAPSHOT
11.1.2. FINANCIAL PERFORMANCE
11.1.3. PRODUCT OFFERINGS
11.1.4. KEY STRATEGIC INITIATIVES
11.1.5. SWOT ANALYSIS
11.2. CORNEAGEN INC.
11.2.1. COMPANY SNAPSHOT
11.2.2. FINANCIAL PERFORMANCE
11.2.3. PRODUCT OFFERINGS
11.2.4. KEY STRATEGIC INITIATIVES
11.2.5. SWOT ANALYSIS
11.3. CORNEAT VISION
11.3.1. COMPANY SNAPSHOT
11.3.2. FINANCIAL PERFORMANCE
11.3.3. PRODUCT OFFERINGS
11.3.4. KEY STRATEGIC INITIATIVES
11.3.5. SWOT ANALYSIS
11.4. LINKOCARE LIFE SCIENCES AB
11.4.1. COMPANY SNAPSHOT
11.4.2. FINANCIAL PERFORMANCE
11.4.3. PRODUCT OFFERINGS
11.4.4. KEY STRATEGIC INITIATIVES
11.4.5. SWOT ANALYSIS
11.5. PRESBIA PLC
11.5.1. COMPANY SNAPSHOT
11.5.2. FINANCIAL PERFORMANCE
11.5.3. PRODUCT OFFERINGS
11.5.4. KEY STRATEGIC INITIATIVES
11.5.5. SWOT ANALYSIS
11.6. MEDIPHACOS
11.6.1. COMPANY SNAPSHOT
11.6.2. FINANCIAL PERFORMANCE
11.6.3. PRODUCT OFFERINGS
11.6.4. KEY STRATEGIC INITIATIVES
11.6.5. SWOT ANALYSIS
11.7. AUROLAB
11.7.1. COMPANY SNAPSHOT
11.7.2. FINANCIAL PERFORMANCE
11.7.3. PRODUCT OFFERINGS
11.7.4. KEY STRATEGIC INITIATIVES
11.7.5. SWOT ANALYSIS
11.8. CORNEAL BIOSCIENCES
11.8.1. COMPANY SNAPSHOT
11.8.2. FINANCIAL PERFORMANCE
11.8.3. PRODUCT OFFERINGS
11.8.4. KEY STRATEGIC INITIATIVES
11.8.5. SWOT ANALYSIS
11.9. DIOPTEX GMBH
11.9.1. COMPANY SNAPSHOT
11.9.2. FINANCIAL PERFORMANCE
11.9.3. PRODUCT OFFERINGS
11.9.4. KEY STRATEGIC INITIATIVES
11.9.5. SWOT ANALYSIS
11.10. EYEYON MEDICAL
11.10.1. COMPANY SNAPSHOT
11.10.2. FINANCIAL PERFORMANCE
11.10.3. PRODUCT OFFERINGS
11.10.4. KEY STRATEGIC INITIATIVES
11.10.5. SWOT ANALYSIS
*The list of company is subject to change during the final compilation of the report

Key Companies
  • AJL Ophthalmic
  • CorneaGen Inc.
  • CorNeat Vision
  • LinkoCare Life Sciences AB
  • Presbia plc
  • Mediphacos
  • Aurolab
  • Cornea Biosciences
  • DIOPTEX GmbH
  • EyeYon Medical
Market Segments

By Type

  • Human Cornea
  • Artificial Cornea

By Transplant Type

  • Penetrative Keratoplasty
  • Endothelial Keratoplasty
  • Anterior Lamellar Keratoplasty
  • Keratoprosthesis

By Disease Indication

  • Fuschs’ Dystrophy
  • Fungal Keratitis
  • Keratoconus
  • Others

By End Users

  • Hospitals & Ambulatory Surgical Centers
  • Specialty Clinics

By Regions 

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The global protein A resin market was valued…
The infectious diseases diagnostics market was valued at…
The global pulse oximeter market was valued at…